Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

BACKGROUND: To conduct a real-word-study-based cost-effectiveness analysis of a GLP-1 receptor agonist (GLP-1RA) versus insulin among type 2 diabetes patients requiring intensified injection therapy and a systematic review of cost-effectiveness studies of GLP-1RAs versus insulin. METHODS: Individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chen-Yi, Chen, Ying-Ren, Ou, Huang-Tz, Kuo, Shihchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816439/
https://www.ncbi.nlm.nih.gov/pubmed/33468131
http://dx.doi.org/10.1186/s12933-020-01211-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816439/
https://www.ncbi.nlm.nih.gov/pubmed/33468131
http://dx.doi.org/10.1186/s12933-020-01211-4

Ejemplares similares